Ticker brief
MESO
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
12
authors 14d
8
crowd 14d
-1.5σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-28 · now +0.20 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BiopharmIQ | B | · | 3 | +0.28 |
| @AlertsAndNews | C | -1.90 | 2 | +0.43 |
| @ClassicRoy | C | -1.52 | 2 | +0.00 |
| @doublejtrading | C | -1.82 | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.40 |
| @HedgeFundTips | B | +0.49 | 1 | +0.10 |
| @CrweWorld | C | · | 1 | +0.30 |
| @MinervaCap | C | -0.39 | 1 | +0.00 |
Recent signals12of 12 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @BiopharmIQ | +0.40 | Summarizes major weekly biotech gainers and BTAI's bankruptcy-driven 75% decline | · | tweet ↗ |
| 2026-08-28 | @ClassicRoy | +0.00 | Lists options with decreasing implied volatility. | · | tweet ↗ |
| 2026-08-27 | @MinervaCap | +0.00 | Daily watchlist names tomorrow's top trade candidates but gives no entries, levels or directional mechanics. | · | tweet ↗ |
| 2026-08-27 | @BiopharmIQ | +0.25 | Biotech mover list links price changes to company-specific catalysts. | · | tweet ↗ |
| 2026-08-26 | @AlertsAndNews | +0.60 | Reports FY2026 revenue of $120M and gross profit of $104M amid product adoption growth. | · | tweet ↗ |
| 2026-08-26 | @CrweWorld | +0.30 | Reports substantial company revenue growth to $120 million. | · | tweet ↗ |
| 2026-08-25 | @ClassicRoy | +0.00 | Lists securities with declining options implied volatility. | · | tweet ↗ |
| 2026-08-17 | @BiopharmIQ | +0.20 | Biotech news list reports FDA acceptance, positive trials, a merger, placement and severe data-related move. | · | tweet ↗ |
| 2026-08-17 | @HedgeFundTips | +0.10 | Presents a broad list of stocks receiving money flows, with details apparently contained in linked media. | · | tweet ↗ |
| 2026-08-17 | @OpenOutcrier | +0.40 | Mesoblast completed patient treatment in a pivotal Phase 3 chronic-low-back-pain trial. | · | tweet ↗ |
| 2026-08-17 | @doublejtrading | +0.00 | Publishes a broad gapper list without individual directional interpretation. | · | tweet ↗ |
| 2026-08-16 | @AlertsAndNews | +0.25 | Reports completion of patient treatment in a pivotal Phase 3 chronic-low-back-pain trial. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.